LONDON -- Arthritis medication developed by Japan's Chugai Pharmaceutical provides effective treatment against the novel coronavirus, according to the British government, lowering mortality risk and shortening hospital stays.
Coronavirus
Japanese arthritis drug Actemra effective against COVID, UK says
Study finds medication lowers risk of death by 24% and shortens ICU stays
Authorization to use the arthritis medication as a COVID-19 treatment comes as cases top 50,000 a day in the U.K., taxing hospital resources. © Reuters
Read Next
Latest on Coronavirus
